Prescribe an SGLT2 inhibitor for heart failure in the absence of diabetes?

被引：2
|
作者：
Koenigsberger, Debra [1 ]
Marquez, Alexander [1 ]
Hughes, Pamela R. [1 ]
Mullen, Rebecca [2 ]
机构：
[1] Nellis AFB Family Med Residency, Las Vegas, NV USA
[2] Univ Colorado, Dept Family Med, Denver, CO 80202 USA
来源：
JOURNAL OF FAMILY PRACTICE | 2021年 / 70卷 / 06期
关键词：
RISK;
D O I：
10.12788/jfp.0235
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：E7 / E9
页数：3
相关论文
共 50 条
  • [41] More Evidence for SGLT2 Inhibitors in Heart Failure
    Jarcho, John A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1481 - 1482
  • [42] Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
    Theofilis, Panagiotis
    Oikonomou, Evangelos
    Tsioufis, Konstantinos
    Tousoulis, Dimitris
    LIFE-BASEL, 2023, 13 (02):
  • [43] SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure-A Concise Review
    Keller, Daria M.
    Ahmed, Natasha
    Tariq, Hamza
    Walgamage, Malsha
    Walgamage, Thilini
    Mohammed, Azad
    Chou, Jadzia Tin-Tsen
    Kaluzna-Oleksy, Marta
    Lesiak, Maciej
    Straburzynska-Migaj, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [44] The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
    Berezin, Alexander A.
    Obradovic, Zeljko
    Fushtey, Ivan M.
    Berezina, Tetiana A.
    Novikov, Evgen V.
    Schmidbauer, Lukas
    Lichtenauer, Michael
    Berezin, Alexander E.
    BIOMEDICINES, 2023, 11 (02)
  • [45] Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus
    Nakagaito, M.
    Joho, S.
    Ushijima, R.
    Nakamura, M.
    Hirai, T.
    Kinugawa, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1030 - 1030
  • [46] Diabetes and SGLT2 Inhibitor Treatment Alter Podocyte Glycocalyx
    Becerra Calderon, Alejandra
    Alkoraishi, Hasen
    Izuhara, Audrey
    Deepak, Sachin K.
    Trogen, Greta H.
    Peti-Peterdi, Janos
    Gyarmati, Georgina
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [47] Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor
    Ren, Qian
    Gong, Siqian
    Han, Xuyao
    Ji, Linong
    JOURNAL OF DIABETES, 2022, 14 (03) : 216 - 220
  • [48] Severe ketoacidosis in a patient taking SGLT2 inhibitor for diabetes
    Hatlen, Kristine Vaage
    Sharma, Archana
    Nermoen, Ingrid
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2020, 140 (12) : 1267 - 1269
  • [49] Incidence and potential predictors of SGLT2 inhibitor initiation in acutely hospitalized patients with heart failure
    Lanier, Cameron
    Brumit, Jessica C.
    Tharp, Jennifer
    Crawford, Jacquelyn
    White, Kathleen M.
    Wilson, Vera
    Covert, Kelly
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025,
  • [50] Circulating ketone bodies in patients with acute heart failure treated with the SGLT2 inhibitor empagliflozin
    Voorrips, S. N.
    Boorsma, E. M.
    Beusekamp, J. C.
    De Boer, R. A.
    Connelly, M. A.
    Dullaart, R. P. F.
    Van Der Meer, P.
    Van Veldhuisen, D. J.
    Voors, A. A.
    Damman, K.
    Westenbrink, B. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 195 - 196
12345